Osteochondral Lesion of Talus

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
MicrofractureN/A1 trial
Active Trials
NCT05741983Withdrawn0Est. Feb 2024

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Geistlich PharmaMicrofracture

Clinical Trials (1)

AMIC vs. MFx in the Ankle

Start: Apr 2023Est. completion: Feb 20240
N/AWithdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space